Table 2.
MMRV |
MMR |
||||
---|---|---|---|---|---|
(MMRV/MMRV group) |
(Pooled (MMR/MMRV)+ (MMR/MMR+V) groups) | Difference in percentage (MMRV−MMR) | |||
Antibody | N* | Per cent† | N* | Per cent† | Per cent‡ (95% CI) |
Measles | 148 | 93.2 | 225 | 88.0 | 5.24 (−1.06 to 11.13) |
Mumps | 144 | 86.1 | 224 | 83.9 | 2.18 (−5.66 to 9.42) |
Rubella | 149 | 98.7 | 225 | 99.6 | −0.90 (−4.36 to 1.29) |
Varicella | 138 | 94.2 | – | | – |
*Number of children initially seronegative with available results.
†Percentage of children who seroconverted for each antigen.
‡Difference in percentage of children who seroconverted for each antigen between the MMMR/MMRV group and the pooled MMR results from the (MMR/MMRV+MMR/MMR+V) groups.
ATP, according-to-protocol; MMR, measles-mumps-rubella vaccine; MMRV, measles-mumps-rubella-varicella vaccine; MMR+V, MMR+varicella vaccine.